TOKYO, November 18, 2021 --Chugai Pharmaceutical Co., Ltd.(TOKYO: 4519) announced the following personnel changes, effective January 1, 2022.
[Details of Personnel Changes]
Executive Officers
Name
New Responsibilities
Current Responsibilities
Toshiaki Itagaki
Executive Vice President
Executive Vice President
CFO
CFO
Head of Finance Supervisory Div.
Head of Finance Supervisory Div.
Supervisory responsibility for
Supervisory responsibility for
Finance & Accounting,
Finance & Accounting,
Corporate Communication,
Corporate Communication,
Purchasing, Digital Transformation
Purchasing, Digital Strategy, IT
Solution
Hiroyuki
Vice President
Vice President
Matsumoto
Marketing & Sales Div.
Head of Kanto-Minami Regional
Management Office,
Marketing & Sales Div.
Satoko Shisai
Vice President
Vice President
Head of Digital Transformation Unit
Head of Digital & IT Supervisory
Division
Department Heads
Name
New Responsibilities
Current Responsibilities
Tetsuya
Head of Audit Dept.
Head of Internal Audit Group 1,
Kobayashi
Audit Dept.
Koma Oki
Head of Research Support Dept.,
Head of HR Planning Group,
Research Div.
Human Resources Management
Dept.
Yasufumi Ueda
Head of CMC Development Dept.,
Deputy Head of API Process
Pharmaceutical Technology Div.
Development Dept.,
Pharmaceutical Technology Div.
Toshimitsu Ikoma
Head of Kanto-Minami Regional
Head of Chugoku and Shikoku
Management Office,
Regional Management Office,
Marketing & Sales Div.
Marketing & Sales Div.
Department Heads (cont.)
Name
New Responsibilities
Current Responsibilities
Ryuu Kondo
Head of Chugoku and Shikoku
Head of Hokkaido and Tohoku
Regional Management Office,
Regional Management Office Kita-
Marketing & Sales Div.
Tohoku Branch,
Marketing & Sales Div.
Group Company
Name
New Responsibilities
Current Responsibilities
Hitomichi Goto
President of Chugai Business
Head of HR Management Group,
Solution Co., Ltd.
Human Resources Management
Dept.
###
2/ 2
Attachments
Original Link
Original Document
Permalink
Disclaimer
Chugai Pharmaceutical Co. Ltd. published this content on 18 November 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 18 November 2021 08:11:10 UTC.
Chugai Pharmaceutical Co. Ltd specializes in the research, development, manufacturing and marketing of drugs especially for cancers (40.8% of net sales), bones and joints diseases treatment (18.4%), and kidney diseases (5.9%).
Net sales are distributed geographically as follows: Japan (74,3%), Switzerland (22,8%) and other (2,9%).